Sinco Pharmaceutical Holdings Ltd
Company Profile
Business description
Sinco Pharmaceutical Holdings Ltd is an investment holding company that deals in marketing, promotion, and channel management of improved human plasma-based pharmaceuticals, antibiotics, and other pharmaceuticals. The company operates in three business segments, namely biologics, medical aesthetic products, and biopharmaceutical cold chain and supply chain services. The biologics business provides marketing, promotion, and channel management services, while the medical aesthetic products business focuses on research and development, production, and sales of aesthetic medicine in China. The biopharmaceutical cold chain and supply chain services concentrate on the construction of cold chain facilities for biopharmaceutical products and establishing the supply chain service platform.
Contact
No. 1700, North Section of Tianfu Avenue
E5-1805, Global Centre
High-Tech Zone, Chengdu
Sichuan Province
Chengdu
CHNT: +86 2862912988
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2025
Employees
291
Stocks News & Analysis
stocks
CBA earnings: The only thing that puzzles us is the share price
stocks
The best way to get rich and retire early
stocks
Investors too optimistic about ASX growth story
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,103.10 | 47.20 | -0.52% |
| CAC 40 | 7,804.97 | 51.55 | 0.66% |
| DAX 40 | 24,185.59 | 160.81 | 0.67% |
| Dow JONES (US) | 44,767.28 | 308.67 | 0.69% |
| FTSE 100 | 9,165.23 | 17.42 | 0.19% |
| HKSE | 25,613.67 | 643.99 | 2.58% |
| NASDAQ | 21,701.54 | 19.64 | 0.09% |
| Nikkei 225 | 43,274.67 | 556.50 | 1.30% |
| NZX 50 Index | 12,766.54 | 6.86 | 0.05% |
| S&P 500 | 6,453.32 | 7.56 | 0.12% |
| S&P/ASX 200 | 8,827.10 | 53.70 | -0.60% |
| SSE Composite Index | 3,683.46 | 17.55 | 0.48% |